Clinical Trial Update: Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the pharmacokinetics and safety of BI 201335 in Hepatitis C patients with varying degrees of renal impairment; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BI 201335

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2015-07-31